NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
3.760
-0.120 (-3.10%)
Apr 29, 2026, 10:56 AM EDT - Market open
NervGen Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 304 | 446 | 153 | 122 | 70 | 97 | |
| Market Cap Growth | 111.77% | 190.81% | 26.05% | 74.14% | -27.73% | 58.13% | |
| Enterprise Value | 298 | 438 | 138 | 111 | 50 | 90 | |
| Last Close Price | 3.88 | 5.60 | 2.18 | 2.04 | 1.19 | 2.13 | |
| PB Ratio | 121.87 | 175.77 | 85.59 | -79.93 | 7.02 | 7.27 | |
| P/TBV Ratio | 140.35 | 199.21 | 104.44 | - | 7.25 | 7.48 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.04 | -0.10 | 0.02 | - | |
| Net Debt / Equity Ratio | -6.34 | -6.34 | -6.66 | 5.71 | -1.65 | -1.01 | |
| Net Debt / EBITDA Ratio | 0.88 | 0.88 | 0.68 | 0.65 | 0.97 | 1.33 | |
| Net Debt / FCF Ratio | 1.13 | 1.13 | 1.02 | 1.01 | 1.25 | 2.05 | |
| Quick Ratio | 1.12 | 1.12 | 1.05 | 0.79 | 2.20 | 15.76 | |
| Current Ratio | 1.16 | 1.16 | 1.13 | 0.83 | 2.27 | 16.16 | |
| Return on Equity (ROE) | -1457.57% | -1457.57% | -8546.24% | -390.89% | -136.87% | -111.94% | |
| Return on Assets (ROA) | -73.42% | -73.42% | -96.17% | -59.88% | -68.90% | -65.17% | |
| Return on Capital Employed (ROCE) | -721.30% | -721.30% | -973.90% | 933.90% | -168.60% | -76.20% | |
| Earnings Yield | -10.25% | -7.22% | -11.00% | -13.94% | -21.93% | -10.41% | |
| FCF Yield | -4.54% | -3.19% | -7.64% | -7.04% | -18.84% | -6.77% | |
| Buyback Yield / Dilution | -7.44% | -7.44% | -13.55% | -12.61% | -34.00% | -22.35% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.